1 - 1 out of 1Page size: 10
  1. 2016

  2. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME (R) trial

    EMPA-REG OUTCOME Investigators, 14 May 2016, In: European Heart Journal. 37, 19, p. 1526-1534 9 p.

    Research output: Contribution to journal › Article › peer-review

ID: 9405604